Replies to post #3608 on Athersys Inc (ATHXQ)

[BooDog]

Maybe they found a solid buyer for the offering.

https://finance.yahoo.com/news/athersys-reschedules-third-quarter-conference-135500220.html

ATHX
-56.45%
Thu, November 10, 2022 at 5:55 AM·2 min read

In this article:

ATHX
-56.45%

CLEVELAND, November 10, 2022--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that it intends to file its quarterly report on Form 10-Q for the three months ended September 30, 2022 with the U.S. Securities and Exchange Commission (SEC) after market close on Monday, November 14, 2022, issue a news release reporting those financial results and recent business highlights before market open on Tuesday, November 15, 2022, and hold a conference call at 11:00 a.m. Eastern Time on Tuesday, November 15, 2022.

The company is rescheduling the reporting of its third quarter 2022 financial results in order to provide sufficient time to complete the Form 10-Q specifically regarding the accounting for recently issued equity warrants.

Details of the rescheduled conference call are as follows:

Date

November 15, 2022

Time

11:00 a.m. (Eastern Time)

Live webcast registration

Webcast link

Phone registration

Call registration link

Shareholders are encouraged to register and listen to the call using the webcast link above. Once registered, you will receive an email containing the toll-free number, a direct entry passcode and a registrant ID. Please send questions you would like management to address in advance of the call to [e-mail]. If you have already registered for this call, your registration will automatically roll over to the new date and time.